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Use of Transition Probabilities to Estimate the Effect of Smoking on the
Duration of Episodes of Respiratory Symptoms in Diary Data
The Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA)
Reinhard Kaiser,1 Christian Schindler,1 Nino Kunzli,1 Ursula Ackermann-Liebrich,1 Dominik Heeb,1
Tullio C. Medici,2 Jean Pierre Zellweger,3 and the SAPALDIA Team
Incompletely documented symptom episodes pose methodological problems in the analysis of diary data.
The aim of this study was to develop a method of estimating the average durations of symptomatic and
nonsymptomatic episodes, respectively, coping with the problem of bias due to undocumented days and
censored episodes that is found in most diary studies. The authors derived their outcome variables from a
Markov model using transition probabilities. To evaluate this method, the authors assessed the impact of
active smoking on the duration of episodes of bronchitis symptoms and the corresponding nonsymptomatic
periods, respectively, using diary data (1992-1993) obtained from 801 participants in the Swiss Study on Air
Pollution and Lung Diseases in Adults. Covariate-adjusted distribution curves for the mean durations of
individual episodes were estimated by Cox regression. Median values for light smokers (<10 cigarettes/day)
were 60.0 symptom-free days (95% confidence interval (Cl) 42.0-78.5) and 4.0 symptomatic days (95% Cl
3.0-6.0), respectively, compared with medians of only 21.0 days (95% Cl 16.2-29.8) for periods without
bronchitis symptoms and 6.0 days (95% Cl 4.9-9.0) for episodes of bronchitis symptoms in heavy smokers
(s30 cigarettes/day). The authors suggest that the Markov method is a feasible approach to the assessment
of long term effects of smoking and environmental risk factors on the average duration of symptomatic and
nonsymptomatic respiratory episodes. Am J Epidemiol 1998;148:600-8.
data collection; epidemiologic methods; longitudinal studies; Markov chains; respiration; smoking
Diaries in which study participants record respira-
tory symptoms are known to be valuable data collec-
tion instruments in air pollution epidemiology. Such
data normally consist of sets of sequences of binary
outcomes, one for each symptom and participant.
Short to medium term effects of air pollution on health
endpoints such as symptom incidence and prevalence
(1-10) and, more recently, symptom duration (11, 12)
have been a major focus of diary studies. However, the
use of diary data for assessment of long term associations
between exposure to environmental risk factors and in-
dividual respiratory health has gained less attention.
One approach is to focus on individual patterns of
symptoms instead of summarizing these data over
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Abbreviations: Cl, confidence interval; FEV,, forced expiratory
volume In 1 second; SAPALDIA, Swiss Study on Air Pollution and
Lung Diseases in Adults.
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time, as is done in time series analyses (13). The
underlying hypothesis is that living in areas with high
concentrations of air pollutants results in increased
symptom prevalence, incidence (i.e., shorter nonsymp-
tomatic periods), or duration of symptoms. The assess-
ment of symptom duration poses special methodolog-
ical problems because of the presence of days with
missing information and the limitation of observation
periods by design. If the duration of a symptomatic
episode is defined as the number of consecutive days
of reported symptoms (12), this implies that the epi-
sode is preceded and followed by at least one day
without symptoms. Using this naive approach, a symp-
tomatic interval cannot be counted as a single episode
if there is even one day with missing information.
Generally, there are two conflicting goals in diary
studies: On the one hand, study periods should be long
enough to estimate the duration of symptomatic epi-
sodes accurately, and the total number of days with
reported data should be large enough to detect differ-
ences in the duration of symptoms between different
categories of subjects. On the other hand, the compli-
ance of most subjects decreases with the length of the
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diary periods and the total number of diary days. In
addition to the general problem of incompletely ob-
served episodes at the beginning and end of the ob-
servation period, a study may be designed in such a
way that subjects fill in the diaries during several
intermittent time periods, which results in discontinu-
ous reporting.
In the Swiss Study on Air Pollution and Lung Dis-
eases in Adults (SAPALDIA), participants in the
follow-up study were asked to fill in diaries during six
periods of 4 weeks spread out over 2 years. To cope
with the problems of missing data for some days and
discontinuous reporting, we used transition probabili-
ties to estimate the effects of ambient pollution on the
durations of symptomatic episodes and corresponding
symptom-free periods (hereafter called nonsymptom-
atic episodes). Here we demonstrate the advantages
and disadvantages of such an approach using the ef-
fects of cigarette smoking on the individual average
durations of episodes with and without bronchitis
symptoms.
MATERIALS AND METHODS
Study design
SAPALDIA consisted of a multicenter, population-
based cross-sectional investigation (1991) with a diary
study as a longitudinal component (1992-1993). It
was designed to evaluate associations between air
pollution and respiratory symptoms and diseases. A
detailed description of the cross-sectional study has
been given elsewhere (14). The eight study areas
(Aarau, Basel, Davos, Geneva, Lugano, Montana,
Payerne, and Wald) represented a wide range of ur-
banization, altitude, air pollution, and meteorologic
conditions in Switzerland. A random sample of adults
aged 18-60 years was drawn from registries of the
inhabitants of these areas. Successfully recruited
subjects (59 percent) were interviewed with an ex-
tended version of the European Respiratory Survey
Questionnaire and underwent allergy and lung func-
tion tests (15).
In the longitudinal portion of the study, subjects
with a higher probability of reporting respiratory
symptoms were oversampled to enhance the study's
statistical power to detect associations between air
pollution and lung diseases. Accordingly, meeting one
of the following criteria assessed in the cross-sectional
study was sufficient for a subject to be eligible for
participation in the diary study: 1) an affirmative an-
swer to at least one of a set of 10 questions on
respiratory symptoms; 2) a ratio between forced expi-
ratory volume in 1 second (FEVj) and forced vital
capacity mat was less than 80 percent of the value
predicted by European Community Coal and Steel
norms; 3) a decline in FEV, of at least 20 percent from
baseline during the bronchochallenge test; and 4) sat-
isfying none of the above criteria and being a non-
smoker. All subjects fulfilling at least one of the first
three criteria were invited to participate. The control
cohort, those fulfilling the fourth criterion, was re-
stricted to a random sample of 150 nonsymptomatic
nonsmokers per area. Thus, all smokers in the follow-
up sample were either symptomatic or hyperreactive.
In each study area, the subjects invited to participate
were randomly assigned to 16 groups of equal size.
The 16 groups were enrolled in the study at intervals
of 1 week to contribute diaries kept for 4 consecutive
weeks. Each diary period was followed by a break
of 12 weeks; thus, participants could complete up to
six diary periods of 4 weeks during the 2 years of
the follow-up study. Therefore, in each week of the
follow-up study (except the weeks at the beginning or
the end), four groups were filling in diaries. Random-
ization of groups was done in a stratified way in order
to guarantee that proportions between cohorts varied
as little as possible from week to week. The partici-
pation rate for the diary study was 61 percent (3,281 of
5,383 persons).
During the diary completion periods, participants
had to record daily data on morbidity parameters (re-
spiratory symptoms, medication use, and peak expira-
tory flow) and other relevant information (time spent
outdoors, absence from the study area, physical activ-
ity, and number of cigarettes smoked).
We restricted our analysis to cigarette smokers. A
total of 801 follow-up participants who had been iden-
tified as current smokers in the cross-sectional study
were still reported to be smokers during the diary
study. The sample was divided into four categories by
number of cigarettes smoked per day, based on cross-
sectional study data (1-9, 10-19, 20-29, and >30
cigarettes/day).
Respiratory symptoms
The 1-week diaries were designed to be filled in
daily in the morning and evening from Monday
through Sunday. Information on some respiratory
symptoms—wheezing, dyspnea, chest tightness, and
cough—was requested both in the morning (for the
preceding night) and in the evening. Other symp-
toms—phlegm, sore throat, hoarseness, running or
blocked nose, itchy or irritated eyes, and fever—had
to be reported in the evening only (for the entire
24-hour period). If no symptoms were reported either
in the morning or at night, a response indicating "no
symptoms experienced" had to be entered.
Am J Epidemiol Vol. 148, No. 6, 1998
602 Kaiser et al.
Because bronchitis is known to be strongly associ-
ated with smoking, bronchitis symptoms were selected
for the analysis. They were defined as the presence of
cough and/or phlegm during the day and/or at night.
Days with missing information
An absence of more than 8 hours from the study
location had to be noted in the diary for that particular
day. For instance, if the absence lasted for a whole
weekend, the participant was asked to fill in the diary
only in the morning before leaving and at night when
he or she came back the next day. For longer absences,
the participant was asked to leave out the whole diary
week and to restart recording after coming back. Since
the present investigation was not directed at short term
effects, days with absences were not generally ex-
cluded from the analysis, but they were one source of
missing information.
If diurnal symptom status was not reported, the day
was declared symptom-free, provided that nocturnal
symptoms were explicitly denied and that evening
peak expiratory flow was measured. The slight under-
estimation of symptom prevalence resulting from this
definition outweighs the opposite bias introduced
by excluding such days from analysis. All other days
with incomplete symptom reports were defined as
"missing."
Statistical analysis
In a first step, we estimated transition probabili-
ties—i.e., the probabilities of becoming symptomatic
or asymptomatic, respectively, from one day to anoth-
er—and the durations of symptomatic and nonsymp-
tomatic episodes for each subject. This estimation was
based on a Markov model. Secondly, we assessed the
impact of cigarette smoking on these previously esti-
mated outcome measures, using covariate-adjusted
Cox regression to calculate confidence intervals for
the median durations. Additionally, we compared the
estimates obtained from the Markov model with the
average durations of completely observed symptom-
atic episodes (naive method).
Outcome measures. Our outcome measures—i.e.,
estimates of the individual average durations of non-
symptomatic and symptomatic episodes, respective-
ly—were derived from a Markov model describing
day-to-day changes in symptom status. Since only the
presence or absence of symptoms was recorded, a
binary model was appropriate. For simplicity, we as-
sumed the individual series to be stationary and tran-
sition probabilities to depend only on the symptom
status of the previous day. Our model was based on the
following assumptions:
1. The probability q of getting a symptom on the
next day is constant (i.e., it does not depend on
the number of symptom-free days prior to the
current day).
2. The probability p of becoming symptom-free
on the next day is constant (i.e., it does not
depend on the number of symptomatic days
prior to the current day).
If this model holds true, then in the long run the
percentage of symptomatic days is ql(q + p), and the
percentage of symptom-free days is pl\q + p). More-
over, the mean length of symptom-free periods is \lq,
and the mean length of symptomatic episodes is lip.
Now, q and p may be estimated as follows:
"01
"01 + "oo
and
P =
where 5 = 0 represents a symptom-free day and 5 =
1 represents a symptomatic day and
noi = number of transitions from 5 = 0 to 5 = 1;
«oo = number of transitions from 5 = 0 to 5 = 0;
/tio = number of transitions from 5 = 1 to 5 = 0;
nu = number of transitions from 5 = 1 to 5 = 1.
Under this model (i.e., of a first-order stationary bi-
nary Markov chain), the remaining number of episode
days after the initial day of symptoms follows a geo-
metric distribution with parameter p. Thus, the average
duration of a symptomatic episode equals 1 + (1 —
p)lp = \lp = (n,, + nw)/nw (16). Likewise, the
average duration of a nonsymptomatic episode equals
Vq = («oo + "oiV"oi- O v e r a l°n8 an^ completely
documented period with a sufficiently large number of
symptomatic and nonsymptomatic episodes, respec-
tively, one would almost certainly have («,, + n10)/
n,0 «* (number of days within completely documented
symptomatic episodes)/(number of completely docu-
mented symptomatic episodes). Therefore, asymptoti-
cally, our method of estimating the average duration of
symptomatic episodes is equivalent to the naive
method for subjects with variable symptom status in
the ideal situation of complete documentation. By
symmetry, the same also holds true for our estimates
of the average duration of nonsymptomatic episodes.
Since the naive method does not require any assump-
tions other than data completeness, this asymptotic
Am J Epidemiol Vol. 148, No. 6, 1998
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equivalence indicates that potential limitations of our
method are not primarily related to the fact that it was
derived from a simplistic model of symptom dynamics
but rather are related to the assumption that missing
days (days with missing data) are independent of
symptom status.
For 56.7 percent of the subjects, transition probabil-
ities could be estimated in this way. The remaining
subjects were divided into the following categories:
1) subjects who reported only symptomatic days or
only symptom-free days, 2) subjects for whom exactly
one of the two transition probability estimates p' and
q' was 0, although they reported both types of symp-
tom status, and 3) subjects for whom both transition
probability estimates p' and q' were 0.
If all documented days (days with documented
symptom status) for a subject are symptom-free, then
only a censored estimate for the average length of this
subject's symptom-free periods is available—i.e., the
number n^ of transitions between consecutive docu-
mented days. Of course, in such a case, no estimate for
the average duration of symptomatic periods is avail-
able. The case in which no symptom-free days have
been reported is completely symmetrical (i.e., with n,,
replacing n^. Approximately 27.7 percent of the es-
timates were censored in this way.
Table 1 shows the proportions of the different ways
in which the estimates were obtained, stratified by
smoking category. The proportions of censored esti-
mates for symptomatic episodes were positively asso-
ciated with increasing numbers of cigarettes smoked
per day (test for trend: p < 0.001), and the proportions
of censored estimates for nonsymptomatic episodes
were negatively associated with numbers of cigarettes
smoked per day (test for trend: p < 0.01).
The following formula for the odds of reporting
symptoms can be used to obtain estimates of p' and q',
respectively, in cases where missing data do not allow
us to apply the original formulas:
_ ql{q + p) _q
~ pKq + P) ~ P '
where/denotes the individual frequency of symptoms.
If q' = 0 and p' > 0, then this formula gives
and if q' > 0 and p' = 0, then one obtains
p = q f
Approximately 12.2 percent of the estimates were
calculated in this way.
If q and p are 0 or missing and censored estimates
are not available, the average durations of nonsymp-
tomatic and symptomatic episodes cannot be calcu-
lated. This may happen if there are few changes in
symptom status and none of them can be clearly lo-
cated in time because of missing data. In 3.4 percent of
the cases, estimates could not be computed. This per-
centage did not vary significantly between smoking
categories (table 1).
Cox regression. In the present analysis, we as-
sessed the effect of cigarette smoking on the average
TABLE 1. Availability of transition probabilities for bronchitis symptoms, SAPALDIAf study, Switzerland, 1992-1993
SmoMng category (clgarettea/day)
Censored estimates
Symptoms on all days***
No symptoms**
Noncensored estimates
q defined; p defined^
q defined; p = O§
q = 0; p defined!]
Estimates not available
q missing; p missing*
%
0
27.2
55.1
8.1
4.4
5.2
1-8
(n» 136)
95%Clt
19.7-34.7
46.8-63.5
3.5-12.7
1.0-7.9
1.4-8.9
%
2.1
26.5
55.6
7.4
6.3
^ 1
10-19
(n=189)
95% Cl
0.1-4.2
20.2^32.7
48.5-62.6
3.5-12.7
2.9-9.8
0.1-4.2
%
3.9
23.9
56.1
7.4
5.3
3.5
20-29
(n = 285)
95% Cl
1.6-6.1
18.9-28.8
50.4-61.9
3.7-11.1
2.7-7.9
1.4-5.6
%
11.0
16.2
59.7
4.2
5.8
3.1
230
(n=191)
95% Cl
6.6-15.4
11.0-21.5
52.7-66.6
1.3-7.0
2.5-9.1
0.7-5.6
** p < 0.01; •** p < 0.001 (test for trend).
t SAPALDIA, Swiss Study on Air Pollution and Lung Diseases in Adults; Cl, confidence interval.
j q = the probability of getting a symptom on the next day; p = the probability of losing a symptom on the next day.
§ p can be calculated by using o/and the frequency of symptomatic days.
U q can be calculated by using p and the frequency of symptomatic days.
# Both q and p cannot be calculated.
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durations of symptomatic and nonsymptomatic epi-
sodes. Because of the presence of censored data (in
subjects without changes in symptom status), Cox
regression was used for this purpose. Multivariate
analysis controlled for sex, age, age2, body mass in-
dex (weight (kg)/height (m)2), study area, season (the
proportion of winter days among all days with docu-
mented symptom status), maternal asthma history,
paternal asthma history, sibling asthma history, and
atopy (defined as a positive skin test). To obtain
covariate-adjusted distribution curves of individual av-
erage durations for each of the four smoking catego-
ries (1-9, 10-19, 20-29, and>30 cigarettes/day), we
used this latter factor as a stratum variable in the Cox
regression model (i.e., a different baseline distribution
function was estimated for each of these categories).
RESULTS
Table 2 shows the distributions of age and body
mass index among males and females in the four
smoking categories. Table 2 also gives the length of
participation for each group and the prevalence of the
factors for which we controlled in the analysis. Heavy
smokers (^30 cigarettes/day) tended to be older, to
have a higher mean body mass index, and to have
fewer documented days than light smokers (<10
cigarettes/day). However, all of these trends were rel-
atively weak. A sibling history of asthma and a posi-
tive skin test were most frequent in light smokers. The
high prevalence of these known predictors of respira-
tory symptoms suggests that they should be controlled
for in a multivariate analysis.
The estimates of episode duration were highly
skewed in all exposure categories. When compared
with the durations of completely observed episodes
(naive method) (figure 1), the estimated durations
were considerably longer (median of 4.0 days vs. 2.3
days) and had a wider distribution (interquartile range
of 5.8 days vs. 2.5 days) and a long tail, with a
maximum of 82 days, as compared with 21 days when
symptomatic episodes could not exceed the 28-day
observation periods by definition. Most of the long
durations of symptomatic episodes were censored es-
timates. Noncensored estimates correlated only
weakly with length of participation (Pearson correla-
tion coefficient = 0.09).
Figure 2 shows covariate-adjusted distribution
curves for the individual average duration of episodes
with bronchitis symptoms in the four smoking catego-
ries; figure 3 shows the corresponding distribution
curves for the individual average duration of intervals
without bronchitis symptoms. As expected, these fig-
ures display opposite trends with increasing numbers
of cigarettes smoked. Periods of bronchitis symptoms
tended to last longer and nonsymptomatic episodes
tended to be shorter in heavy smokers. There was little
difference between the categories of 10-19 cigarettes
per day and 20-29 cigarettes per day regarding the
average duration of symptomatic episodes, or between
the categories of 1-9 cigarettes per day and 10-19
cigarettes per day regarding the average duration of
TABLE 2. ainical characteristic*, participation, and prevalence of control variables, SAPALOIA* study, SwHzeriand, 1992-1993
Mean age (years)
Males
Females
Mean body mass Indext
Males
Females
PartJdpatlont
Days
Periods
Season§
history of maternal
asthma (%)
history oi paternal
asthma (%)
SMng wtth asthma (%)
PosBlve skin test (%)
No.
50
88
1-e
(n=138)
Mean
or
%
39.4
39.3
23.7
22.7
114.3
4.0
051
4.4
7.4
17.6
33.1
SD»
or
95% Cl*
11/4
102
2.6
4 2
54.6
15
023
1.0-7.9
3.0-11.7
112-24.1
252-41.0
No.
80
109
SmoMng category (cigarettes/day)
10-19
(n-189)
Mean
or
%
41.1
41.3
24.4
22.1
116.4
4.1
0.48
5.3
7.4
15.9
18.4
SD
or
95% Cl
11.6
9.7
3.1
25
545
1.9
023
2.1-85
3.7-11.1
10.7-21.1
125-24.0
No.
159
126
20-29
(n = 285)
Mean
or
%
42.0
402
24.8
23.6
107.1
3.8
050
35
6.7
92
18.8
SD
or
95% Cl
10.0
9.7
3.6
4.4
56.1
2.0
025
1.6-6.1
3.8-9.6
5.8-125
14.3-23.4
No.
140
51
230
(n=19
Mean
or
%
42.3
412
25.4
232
107.6
3.8
050
32
5.8
11.8
25.0
1)
SD
or
95% Cl
9.4
6.8
35
35
57.0
ZO
02S
0.7-5.6
2J5-B.1
72-16.3
185-31.1
• SAPALDIA, Swiss Study on Air Pollution and Lung Diseases in Adults; SD, standard deviation; Cl, confidence Interval
t Weight (kgytielght {my.
t Participants were asked to 111 In dartes for six periods of 4 weeks each (168 days).
§ Proportion of winter days among al days wtth symptom status reported.
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FIGURE 1. Estimated individual average durations of bronchitis
symptom episodes (Markov method vs. naive method) among 454
subjects: Swiss Study on Air Pollution and Lung Diseases in Adults,
1992-1993. The 25th, 50th, and 75th percentiles define the lower
edge, Inner line, and upper edge of each box, respectively. Values
exceeding the 75th percentiie by more than 1.5-fold the interquartile
range are plotted individually. The minimum value defines the end of
the lower whisker.
nonsymptomatic episodes. However, the overall dif-
ferences between light (< 10 cigarettes/day) and heavy
(s30 cigarettes/day) smokers were considerable (table
3). We estimated medians of 60.0 symptom-free days
(95 percent confidence interval (CI) 42.0-78.5) and
4.0 symptomatic days (95 percent CI 3.0-6.0), respec-
tively, for light smokers compared with medians of
only 21.0 symptom-free days (95 percent CI 16.2-
29.8) and 6.0 symptomatic days (95 percent CI 4.9-
9.0), respectively, for heavy smokers.
DISCUSSION
In this paper, we have provided a simple and effi-
cient method of dealing with diary data from a 2-year
study in which subjects recorded information during
several separate 4-week periods. This type of partici-
pation was less demanding for participants than a
single 6-month diary period. A design with multiple
intermittent diary periods results in an increased num-
ber of symptomatic and nonsymptomatic episodes ex-
ceeding the limits of the documented periods, adding
to the problem of missing data encountered in diary
studies. Since the symptom duration data tend to be
highly skewed, with a minimum of 1 day and a long
tail (12), a naive approach considering only complete
episodes not only results in a substantial loss of data
but introduces bias towards shorter episodes.
We have shown that the use of a simple Markov
model allows investigators to avoid the problems de-
scribed. A MEDLINE® search suggested that Markov
models are increasingly being used in scientific papers
(37 papers in 1966-1975, 57 in 1976-1983, 178 in
1984-1990, and 258 in 1991-1996). The application
of this method in epidemiology, however, has been
relatively scarce. With regard to environmental epide-
ID
I
1
.2
I
1-9 cigarettes/day
10-19 cigarettes/day
20-29 cigarettes/day
30+ cigarettes/day
50 100 150
Average duration of symptom episodes (days)
FIGURE 2. Distribution of the individual average durations of bronchitis symptom episodes (adjusted for covariates listed in text), by
smoking category: Swiss Study on Air Pollution and Lung Diseases in Adults, 1992-1993.
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51
!
1-9 cigarettes/day
10-19 cigarettes/day
20-29 cigarettes/day
30+ cigarettes/day
S
s
100 150
Average duration of symptom-free episodes (days)
FIGURE 3. Distribution of the individual average durations of episodes without bronchitis symptoms (adjusted for covariates listed in text),
by smoking category: Swiss Study on Air Pollution and Lung Diseases In Adults, 1992-1993.
miology, the model was first applied by Korn and
Whittemore for analyzing the relation between a bi-
nary health response and short term air pollution ex-
posure (17) as a way of avoiding the problems of
previous approaches, such as autocorrelation and
missing values. However, as far as we know, two-
stage approaches, using parameters of a Markov
model as outcomes to be further analyzed, have not
been employed so far. The specific assumptions about
this model do not seem to represent a serious meth-
odological limitation, since our method of estimating
the average duration of symptomatic episodes is as-
ymptotically equivalent to the naive method in the
case of complete data over a long observation period
with a large number of documented symptomatic
episodes. In the case of shorter observation periods,
however, the estimates may exhibit some seasonal
dependency. We therefore used the percentage of
documented days in the winter season as a model
covariate.
In our example, estimates were available for more
than 96 percent of the subjects. To increase this per-
centage, we considered additional steps such as im-
puting data for single missing days, but less than half
of the remaining cases would have been gained for the
analysis. A more sophisticated approach that would be
generally applicable might consist of deriving maxi-
mum likelihood estimates under the assumption that
missing days occur without any relation to symptom
status.
The present model assumes that missing days are
uninformative—i.e., that the mechanisms leading to
days with missing information are unrelated to the
underlying dynamics of symptom status (18). As re-
gards undocumented day-to-day transitions of symp-
tom status at the beginning or end of a diary period,
TABLE 3. Covariate-adjusted estimates* of the individual average durations of bronchitis symptom episodes and corresponding
nonsymptomatic periods (in days), SAPALDIA+ study, Switzerland, 1992-1993
Episodes of bronchitis
symptoms
Periods without bronchitis
symptoms
Median
4.0
60.0
1-9
(no 136)
95%Clt
3.0-6.0
42.0-78.5
Median
6.0
56.0
Smoking category (dgarefles/day)
10-19
(n = 189)
95% Cl
4.2-7.5
47.7-79.0
Median
5.0
46.0
20-29
(n = 285)
95% Cl
4.3-6.0
35.5-56.0
(n =
Median
6.0
21.0
30
191)
95% Cl
4.9-9.0
16.2-29.8
• Adjusted for sex, age, age* body mass index, study area, season, family history of asthma, and atopy (see "Materials and Methods"),
t SAPALDIA, Swiss Study on Air Pollution and Lung Diseases in Adults; Cl, confidence interval.
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this assumption is certainly valid; but it does not match
reality where undocumented day-to-day transitions
within a diary period are concerned. In our example,
the vast majority of subjects (90 percent) had very few
(<5 percent) unexplained missing transitions (i.e.,
transitions for which at least one of the days was
without documented symptom status and without in-
dicated absence from the community). As a conse-
quence of these nonignorable missing days, duration
estimates may be biased to a certain extent. However,
as long as reporting behavior varies little across expo-
sure categories, differences in duration estimates be-
tween these categories may be less affected when
being considered on a relative scale rather than an
absolute scale. To assess the potential magnitude of
this bias, we performed a sensitivity analysis using
the individual percentage of missing transitions as an
additional covariate. While this had almost no effect
on the association between duration of symptom epi-
sodes and smoking intensity, the association between
symptom-free episodes and smoking intensity de-
creased slightly. Moreover, upon analyzing associa-
tions between baseline symptoms (cross-sectional ex-
amination) and individual follow-up symptom
prevalences, we found some suggestion that missing
days were positively associated with symptom-free
status. Further assessment of the potential impact of
nonignorable missing data on duration estimates is
beyond the scope of this analysis.
We tested our method using diary data from
SAPALDIA and obtained plausible estimates for the
effects of smoking on the individual average durations
of bronchitis symptom episodes and corresponding
nonsymptomatic episodes, respectively. Although the
clinical feature of smoking as a risk factor for respi-
ratory ill health is well known, it has not been previ-
ously quantified with regard to symptomatic and non-
symptomatic episodes, to our knowledge. This study
sample consisted of smokers who were either symp-
tomatic or hyperreactive. The true effects of smoking
might even have been underestimated, because of the
fact that heavy smokers may reduce their cigarette
consumption or quit smoking if they become symp-
tomatic.
We suggest that the method of transition probabili-
ties is a feasible approach to the assessment of long
term effects of smoking and environmental risk factors
on the average durations of symptomatic respiratory
episodes and intervals without such symptoms.
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